• Sector
    • Challenges
    • Objectives
    • Strengths and operating rules
  • Organization
    • Expertises & plateforms
    • Members
      • SMEs
      • Pharmaceutical companies
      • Academic partners
    • Institutional partners
    • Partnership
  • Products/services
    • Products/Services
    • Web catalogue
  • News/Events
    • News
    • Events
    • Newsletters
  • Contact
  • Extranet
English
  • French

News

  • Home
  • News
06/11/2019
Publié par Webmaster à 06/11/2019
Catégories
  • News

End-to-end microbiota offering powered by Biofortis

Aimez-vous ?0
Lire le détail
31/10/2019
CTIBioTumour: human microtumours produced by 3D-bioprinting
Publié par Webmaster à 31/10/2019
Catégories
  • News

Predictive tools mimicking disease progression & treatment efficacy

Aimez-vous ?0
Lire le détail
30/10/2019
Publié par Webmaster à 30/10/2019
Catégories
  • News

Design and implementation of precision medicine clinical trials including gut microbiota

Aimez-vous ?0
Lire le détail
18/10/2019
Publié par Webmaster à 18/10/2019
Catégories
  • News

Complementary pre-clinical offering on microbiota powered by Oncodesign At the forefront of precision medicine using microbiota signature

Aimez-vous ?0
Lire le détail
18/10/2019
Publié par Webmaster à 18/10/2019
Catégories
  • News

Scientific breakthrough in breast cancer

Aimez-vous ?0
Lire le détail
123456789101112
Suivant

Imodi_Cancer
A French consortium to develop new experimental models of cancer. Modelizing the diversity of cancers for effective treatments tailored to each patient.

Share this !

Latest news

  • Newsletter IMODI 7 - November 2019
    Discover and Share the Newsletter IMODI #7 – November 2019
    08/11/2019
  • End-to-end microbiota offering powered by Biofortis
    06/11/2019

Quick access

  • The IMODI Sector
  • Organization
  • Products & Services
  • News & Events
  • Newsletters
  • Contact us

IMODI on Twitter

Tweets by @imodi_cancer
Powered by Modul-Bio - © IMODI Cancer - Tous droits réservés
Animated by Essentiel MARKETING

Your name (required)

Your email (required)

Company

Subject

Your message

This website uses cookies to collect anonymous statistical indicators. We'll assume you're ok with this, but you can opt-out if you wish.Accept